A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients With Uncontrolled Severe Asthma
Phase: PHASE2
Conditions: Asthma
Sponsor: Hoffmann-La Roche

Official Title: A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-
Ranging Study to Assess the Efficacy and Safety of MSTT1041A in Patients with Uncontrolled 
Severe Asthma 
NCT Number: NCT02918019 
Document Date: Protocol Version 4: 23 January 2019